Quadria, PE funds eye stake in Samarth Lifesciences; deal may value firm at Rs 4,500 crore
Quadria Capital is eyeing a strategic acquisition of a majority interest in Samarth Lifesciences, a move that could value the transaction at around Rs 4,500 crore. With ambitions for growth, Samarth Lifesciences is on the lookout for investment, especially after…
Read More